The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis

References

• Wender M. Acute disseminated encephalomyelitis (ADEM). J Neuroimmunol. 2011;231(1):92–4. doi:10.1016/j.jneuroim.2010.09.019.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Huo L, Li Q, Chen J, Wang H. SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature. J Neurol. 2022;269(3):1071–92. doi:10.1007/s00415-021-10771-8.
   PubMed Web of Science ®Google Scholar
• Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Clementi E, Radice S. Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems. PloS ONE. 2013;8(10):e77766. doi:10.1371/journal.pone.0077766.
   PubMed Web of Science ®Google Scholar
• Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci. 2008;15(12):1315–22. doi:10.1016/j.jocn.2008.05.002.
   PubMed Web of Science ®Google Scholar
• Brighton Collaboration COVID-19 AESI list. https://brightoncollaboration.us/wp-content/uploads/2021/01/COVID-19-updated-AESI-list.pdf.
   Google Scholar
• Nabizadeh F, Noori M, Rahmani S, Hosseini H. Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review. J Clin Neurosci. 2023;111:57–70. doi:10.1016/j.jocn.2023.03.008.
   PubMed Web of Science ®Google Scholar
• Public Health England. Weekly national influenza and COVID-19 report 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/994577/Weekly_Flu_and_COVID-19_report_w24.pdf.
   Google Scholar
• NHS Digital Secondary Uses Service (SUS). https://digital.nhs.uk/services/secondary-uses-service-sus.
   Google Scholar
• Public Health England. COVID-19: the green book, chapter 14a. In: Immunisation against infectious diseases. London: Public Health England; 2020.
   Google Scholar
• Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine. 2004;22(15–16):2064–70. doi:10.1016/j.vaccine.2004.01.017.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Al-Shahi Salman R, Miller E. Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine. 2011;29(45):7878–82. doi:10.1016/j.vaccine.2011.08.069.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Ladhani S, Miller E. The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation. Vaccine. 2016;34(32):3684–9. doi:10.1016/j.vaccine.2016.04.050.
   PubMed Web of Science ®Google Scholar
• Stowe J, Miller E, Andrews N, Whitaker HJ. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: a self-controlled case series analysis in England. PLoS Med. 2023;20(6):e1004245. doi:10.1371/journal.pmed.1004245.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Miller E, Ramsay M. BA.1 bivalent COVID-19 vaccine use and stroke in England. JAMA. 2023;330(2):184. doi:10.1001/jama.2023.10123.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Miller E. Do vaccines trigger neurological diseases? Epidemiological evaluation of vaccination and neurological diseases using examples of multiple sclerosis, Guillain–Barré syndrome and narcolepsy. CNS Drugs. 2020;34(1):1–8. doi:10.1007/s40263-019-00670-y.
   PubMed Web of Science ®Google Scholar
• Dale RC, Branson JA. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child. 2005;90(6):636. doi:10.1136/adc.2004.062935.
   PubMed Web of Science ®Google Scholar
• Fourrier A, Begaud B, Alperovitch A, Verdier-Taillefer MH, Touze E, Decker N, Imbs JL. Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. Br J Clin Pharmacol. 2001;51(5):489–90. doi:10.1046/j.1365-2125.2001.01364.x.
   PubMed Web of Science ®Google Scholar
• Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B. Hepatitis B vaccination and the putative risk of central demyelinating diseases–a systematic review and meta-analysis. Vaccine. 2018;36(12):1548–55. doi:10.1016/j.vaccine.2018.02.036.
   PubMed Web of Science ®Google Scholar
• Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G. et al. Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med. 2021;385(7):585–94. doi:10.1056/NEJMoa2108891.
   PubMed Web of Science ®Google Scholar
• Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, Hinsley W, Bernal JL, Kall M, Bhatt S, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–12. doi:10.1016/S0140-6736(22)00462-7.
   PubMed Web of Science ®Google Scholar
• Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J query. 2003;79(927):11–17. doi:10.1136/pmj.79.927.11.
   PubMed Web of Science ®Google Scholar
• Walker JL, Schultze A, Tazare J, Tamborska A, Singh B, Donegan K, Stowe J, Morton CE, Hulme WJ, Curtis HJ, et al. Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform. Vaccine. 2022;40(32):4479–87. doi:10.1016/j.vaccine.2022.06.010.
   PubMed Web of Science ®Google Scholar
• Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, Watkinson P, Khunti K, Harnden A, Coupland CAC, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410–22. doi:10.1038/s41591-021-01630-0.
   PubMed Web of Science ®Google Scholar
• Whitaker HJ, Ghebremichael‐Weldeselassie Y, Douglas IJ, Smeeth L, Farrington CP. Investigating the assumptions of the self‐controlled case series method. Stat Med. 2018;37(4):643–58. doi:10.1002/sim.7536.
   PubMed Web of Science ®Google Scholar